Displaying items by tag: school of medicine
Virologist Kevin Harrod, Ph.D., is the institution’s resident expert on SARS viruses. His lab is handling biological validation for innovative drug-repurposing studies supported by the School of Medicine’s Urgent COVID-19 research fund.
Microbiologists Troy Randall and Frances Lund are building key proteins from several coronaviruses to study antibody cross-reactivity and other crucial questions in this project supported through UAB’s urgent COVID-19 research fund.
Beginning with iron lung treatments in the 1950s, UAB has long been committed to the respiratory health of its patients. That continues with its COVID Respiratory Clinic to better evaluate treatments needed for coronavirus patients.
In this project supported through UAB’s urgent COVID-19 research fund, Professor Randall Davis aims to identify antibodies that block SARS-CoV-2 from entering human cells — information that could guide convalescent plasma therapy and more.
In this project supported through UAB’s urgent COVID-19 research fund, Assistant Professor Benjamin Larimer, Ph.D., adapts his lab’s work on phage display — normally used to identify new cancer treatments — to overcome limitations of antibody and vaccine testing.
Vineeta Kumar, M.D., professor in the Division of Nephrology, is one of 12 faculty selected to receive the 2019 UAB President’s Award for Excellence in Teaching.
UAB is part of several trials to test whether an infusion of antibodies from people who have beaten COVID-19 can help those dealing with infection or at risk for infection. Donors are needed.
Wearing appropriate personal protective gear is a simple, yet effective way to do your part to help stop the spread of coronavirus — but only when you do it properly and hygienically, say medical experts.
Trial to rapidly identify and treat the immune overreaction that may be behind some cases of severe COVID-19 is made possible through UAB Medicine’s Urgent COVID-19 Clinical Research and Laboratory Research Fund.
Antibody testing can reveal if a person has been exposed to the novel coronavirus in the past. More research needs to be done before we know if that means they are “protected” from COVID-19.
Educating new primary care physicians about effective treatments for opioid use disorder in partnership with Cahaba Medical Care.
Just in time to tackle COVID-19, the Informatics Institute launches a bigger, more capable version of its team-science data platform.
Talking cutting-edge science and family questions with the first members of UAB's Undergraduate Immunology Program.
Lab-grown human heart tissue could mean better drug tests, faster transplants and more accurate models of disease. To get there, Palaniappan Sethu, Ph.D., is stretching ingenuity.
UAB algorithm offers doctors a step-by-step guide to connect patients with HIV to best smoking-cessation options.
New UAB research is combining mathematical modeling and advanced imaging to find the right mix of therapy for patients with a common subtype of breast cancer.
Emotional intelligence is the top trait of effective leaders. UAB leadership expert Jean Ann Larson, Ed.D., explains how to take control, whether you are managing colleagues or your kids' fears.
Are there differences in the way that minority groups and people with low socioeconomic status experience chronic low back pain? Learn more about an ongoing study in this new series that looks behind the scenes of UAB’s latest grants and contracts.
UAB podcasts can help you stay safe online, sharpen your skills and connect with fellow Blazers.
John Kearney, Ph.D., Distinguished Professor in the Department of Microbiology, will be honored for 45 years of service to UAB during the annual Service Awards banquet March 6.
Learn how UAB researchers are taking on the most feared complication of the new generation of blood-thinning drugs.
You don’t have to build a better mousetrap to move markets — discoveries, artworks, inventions and websites can all qualify for protection. Here are your rights and obligations as a UAB employee with potential IP.
An innovative grant aims to speed up antiretroviral therapy initiation for patients in the Deep South newly diagnosed with HIV.
